↓ Skip to main content

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested…

Overview of attention for article published in BMC Cancer, July 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
twitter
3 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
125 Mendeley